Home Add to Favorite Contact Submit  
           02 May, 2024


    
Category:  Press

 » Health & Fitness

SUBMIT PRESS RELEASE

Press releases Records 311-320 of 360  |  Go to << Prior 1 ... 30 31 32 33 34 ... 36 Next >> page 
Order by  Date Added  |  Popularity  |  Alphabet
Health Care Options For Senior Citizens Easier To Find Online (Popularity: )
http://www.mostmedicare.com
Boca Raton, FL - April 27, 2011 - With the growing popularity of the web, a lot of people are surprised that there is one segment of the American public that is coming online faster than any other age group: senior citizens. This is due to the fact that people in this age range are no longer content simply to send and receive emails, they are looking for ways to ...

The launch of Meddco Android App with new features to make healthcare affordable (Popularity: )
https://www.meddco.com
MUMBAI, India, 20 JULY, 2019 -​​​ Meddco.com® is pleased to announce the reintroduction of its Android and iOS Mobile App and its latest functionality which aims to improve the health of everyday people. The addition of new features made to the Android and iOS app will help patients compare the prices of different healthcare services and choose the most suitable one with a single click. Moreover, it includes dynamic pricing, ...

Eslax(R) (Rocuronium Bromide) Approved in Japan (Popularity: )
http://www.akzonobel.com
Organon, the human healthcare business unit of Akzo Nobel (Euronext Amsterdam: AKZ), today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved rocuronium bromide, its neuromuscular blocking agent (NMBA) for use during general anesthesia, under the brand name Eslax(R). This drug has a fast onset of action and is one of the most widely used muscle relaxants in the United States, Canada and many European countries ...

PanOptica Raises $30 Million in Series A Financing and Licenses Lead Compound for Development as Topical Treatment of AMD (Popularity: )
http://www.panopticapharma.com/
PanOptica, Inc., a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, today announced that it has raised $30 million in a Series A financing. This round was led by SV Life Sciences and Third Rock Ventures.The completion of Series A financing coincides with the company's successful licensing of exclusive worldwide ophthalmic rights to PAN-90806 from OSI Pharmaceuticals, Inc., a wholly owned subsidiary of Astellas US Holding, Inc., ...

American Heart Association/American College of Cardiology Joint Science Advisory: AHA/ACC Issue Advisory on Diabetes Drugs and Heart Risk (Popularity: )
The data are inconclusive on heart risks from a class of blood sugar-lowering drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or rosiglitazone (Avandia), but the medications should be used with close monitoring from healthcare providers according to a joint science advisory from the American College of Cardiology and the American Heart Association.The advisory is published online in both Circulation: Journal of the American Heart Association and Journal of the ...

AIDS Vaccine Advocacy Coalition Calls for Renewed Commitment to Vaccine Research on Anniversary of President Clinton's 10-Year Challenge (Popularity: )
http://avac.org
On May 18, 1997, US President Bill Clinton called for a concerted effort to develop an AIDS vaccine within a decade. This year we mark the 10th anniversary of that call for action with a global AIDS epidemic that rages on, and without a preventive HIV vaccine. "Over the past decade, we have seen great progress in AIDS vaccine development, and we now see signs of great hope for development ...

After Founding Meeting in St. Louis ... Labor Unions Vow Stepped Up Pressure on Congress to Support 'Medicare for All' Approach to Healthcare Reform (Popularity: )
http://www.flickr.com
More than 150 union leaders from 31 states gathered in St. Louis last weekend to step up a grassroots campaign to enact comprehensive national healthcare reform. The group is promoting a single-payer plan, which would work like an improved and expanded Medicare program to cover everyone.The national kick-off meeting was convened by Labor for Single-Payer Healthcare, a campaign spearheaded by scores of trade union organizations. The national single-payer bill, HR ...

DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins (Popularity: )
http://www.crucell.com
DSM Biologics and Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) announced today that they have entered into an agreement with Avid Bioservices, Inc. of Tustin, California to join their Vendor Network. Under the terms of the agreement, Avid will be a pre-approved contract manufacturer (CMO) for licensees of the PER.C6(R) cell line located in the western U.S. Avid is the first U.S.-based contract manufacturer to be awarded this status. ...

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel (Popularity: )
http://www.escardio.org
A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or recurrent heart attacks (7.4 percent vs. 9.7 percent, p<0.0001), regardless of whether the events occurred around the time of an artery-opening procedure known as percutaneous coronary intervention (PCI), or if they occurred spontaneously during the longer-term maintenance phase. The analysis was presented today at the European Society ...

Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting (Popularity: )
http://www.endocare.com
Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologists for tissue and tumor ablation, announced today that cryoablation, a minimally invasive method of freezing cancerous tumors to destroy them, was the focus of 17 clinical studies presented at the six-day annual meeting of the American Urological Association (AUA) in Orlando, which is the largest urology meeting ...